Personal tools

Coexpression cluster:C1098

From FANTOM5_SSTAR

Revision as of 14:41, 26 November 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C1098_acute_teratocarcinoma_myelodysplastic_colon_adult_Mast_merkel



Phase1 CAGE Peaks

Hg19::chrX:80370321..80370336,-p@chrX:80370321..80370336
-
Hg19::chrX:80370650..80370666,-p@chrX:80370650..80370666
-
Hg19::chrX:80371754..80371768,-p@chrX:80371754..80371768
-
Hg19::chrX:80373952..80373966,-p@chrX:80373952..80373966
-
Hg19::chrX:80373978..80373996,-p@chrX:80373978..80373996
-
Hg19::chrX:80377100..80377111,-p5@HMGN5
Hg19::chrX:80377118..80377149,-p1@HMGN5
Hg19::chrX:80377162..80377180,-p2@HMGN5


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br>disease_data<br>


Uber Anatomy
Ontology termp-valuen
neural tube9.45e-1356
neural rod9.45e-1356
future spinal cord9.45e-1356
neural keel9.45e-1356
regional part of forebrain3.64e-1241
forebrain3.64e-1241
anterior neural tube3.64e-1241
future forebrain3.64e-1241
regional part of nervous system1.91e-1153
regional part of brain1.91e-1153
central nervous system6.53e-1181
nervous system8.60e-1189
brain grey matter8.30e-1034
gray matter8.30e-1034
neurectoderm1.02e-0986
pre-chordal neural plate7.50e-0961
regional part of telencephalon8.19e-0932
neural plate1.09e-0882
presumptive neural plate1.09e-0882
adult organism1.46e-08114
telencephalon2.05e-0834
brain2.06e-0868
future brain2.06e-0868
organ system subdivision6.76e-08223
ecto-epithelium7.31e-08104
cerebral hemisphere9.33e-0832
larynx1.45e-079
ectoderm-derived structure7.09e-07171
ectoderm7.09e-07171
presumptive ectoderm7.09e-07171
Disease
Ontology termp-valuen
hematologic cancer1.95e-1851
immune system cancer1.95e-1851
cancer2.79e-17235
disease of cellular proliferation7.13e-17239
leukemia9.48e-1639
myeloid leukemia5.93e-1231
organ system cancer2.60e-10137


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
IRF3#3661317.61823207930860.0004979994386673570.00440096153113726
MAFF#23764321.11825868372940.0002930101691141860.00310803260736507
MAFK#7975310.16277492668620.002445573107139520.0137689061852585
NFYA#480036.909592762436450.007279727237130680.0301235164990171
NFYB#480136.284922470076170.009473769012482620.0356976210230066
PBX3#509038.217942257529050.004473206582808440.0211679756366983
SP2#666839.807573935191740.002707184665085610.014887876322304



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.